Your vision is our mission.

Cure diseases with advanced biologics – make UGA Biopharma your First CHOice^® for your cutting-edge cell lines. We specialize in cost-effective development of high-quality biosimilars and biologics.

Meet our Company!

Products and Services

Cell Line Development

Based on our proprietary technology platform, we develop highly productive cell lines for our customers to support production of premium-quality biopharmaceuticals.

Upstream Processing

Upstream processing for optimal product quality and yield. We develop and optimize processes for your cell lines.

Downstream Processing

Downstream processing with continuous CQA (critical quality attributes) monitoring ensures effective purification of proteins for individually scalable processes.

liquid handling robot for analytical development at uga biopharma

Analytical Method Development

Development of needs-based analysis methods for determination of productivity and CQA (critical quality attributes).

cyropreserved cell bank with multiple frozen vials at uga biopharma

Ready-to-use cell lines

We provide high-quality, ready-to-use cell lines for biosimilars from our UGA Biopharma portfolio of specially adapted CHO host cell lines.

uga biopharmas first choice medium and feeds

First CHOice^®Medium & Feeds

Our First CHOice^® products are based on our proprietary medium and the accurately matched Feed Alpha and Feed Beta nutrient solutions.

News Update

Come and visit us at our booth 20C11 at CPHI 2024

Take the chance to meet us at booth 20C11 and get insights into our newest developments.

First CHOice®: The Single Cell Cloning Solution and Premier Fed-Batch Medium

Discover First CHOice® Media, the ultimate solution for cell culture. Perfect for Single Cell Cloning and Fed-Batch production, ensuring high productivity!

UGA Shines at Berlin Firmenlauf 2024: Team Spirit and Community Engagement in Action!

UGA Biopharma proudly participated in Firmenlauf 2024, with 13 employees joining over 1,000 companies in Berlin for a spirited 5K run!

UGA Biopharma ISO 9001 certified

UGA Biopharma celebrates achieving ISO 9001:2015 certification, solidifying our commitment to top-tier quality in biopharma.

Advancing Rare Disease Solutions – UGA Biopharma’s Commitment to Innovative Therapies

At UGA Biopharma, we're proud to be actively contributing to the worldwide effort against rare diseases.

close up of cho cells used for cell line development at uga biopharma

Visit our NEW website!

We're excited to share that we've given our website a fresh new look!

Come to visit us at our booth 2H20 at CPHI in Barcelona

We're delighted to announce that we're preparing for CPHI 2023 in Barcelona, taking place from the 24th to the 26th of October!

UGA Biopharma on the Festival of Biologics

We very much look forward to the Festival of Biologics in Basel in October.

>50

customer projects for biologics & biosimilars completed

>20

ready-to-use cell lines developed

>3.5M

liters of media and feeds produced

About us: Your vision is our mission

UGA Biopharma GmbH was established in 2009 in Hennigsdorf near Berlin, Germany. UGA Biopharma specializes in the development of monoclonal cell lines for the production of advanced biologics and biosimilars. Thanks to our technology platform and the expertise of our international team, we are able to deliver top-quality processes rapidly and at low cost. Moreover, our portfolio includes ready-to-use cell lines, which allow our customers to get started quickly in biosimilar development for their own production.

Our own products – with the optimally matched First CHOice^® cell culture medium and First CHOice^® feeds – offer a high-grade alternative to other commercially available media and feeds. They ensure excellent productivity of our cell lines, as well as high quality of the products.